is tirzepatide on shortage list The FDA says the Zepbound over. That's rattling the weight loss industry A Major GLP-1 Drug Shortage

The EMA conducted independent reviews of pancreatic safety data for incretin-based therapies, concluding that available evidence did not support a causal relationship with pancreatic cancer

Patients using PlexusDx's compounded semaglutide often find success with a simple framework: protein + vegetable + small whole grain at each meal, with minimal added fats

Another study focusing on liraglutide users reported that 85.6% of participants lost more than 4.4 lbs (2 kg) within 50 days, with an average loss of 10.8 lbs (4.9 kg)

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.American Association for the Study of Liver Diseases